#240 Novel Emerging Therapies in the Targeted Protein Degradation space, CELMoDs in Multiple Myeloma Treatment
Dr. Tania Small joined Bristol Myers Squibb as Senior Vice President, Global Medical Affairs in January 2024. Tania brings a strong scientific track record leading Medical Affairs teams in driving innovation that improves the experience and supports better outcomes of people living with cancer and rare diseases. She has successfully built and led global and regional medical organizations in Drug Development and Medical Affairs, advancing access to Oncology, Rare Disease and Hematology patients globally.
Tania is a board-certified pediatric hematology, oncology, and bone marrow transplant…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.